Vestcor Inc’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

Vestcor Inc’s Portfolio EBAC Stock Details EBAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-35,000	Closed	-$354K	–	1352
2022 Q4	$354K	Hold	35,000	–	–	0.01%	745
2022 Q3	$347K	Hold	35,000	–	–	0.01%	773
2022 Q2	$342K	Hold	35,000	–	–	0.01%	780
2022 Q1	$342K	Hold	35,000	–	–	0.01%	769
2021 Q4	$340K	Hold	35,000	–	–	0.01%	730
2021 Q3	$340K	Hold	35,000	–	–	0.01%	689
2021 Q2	$338K	Buy	+35,000	New	+$344K	0.01%	730

Vestcor Inc's EBAC Position: Q1 2023 in Review

Vestcor Inc sold out of European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) in Q1 2023, closing a stake of 35,000 shares — an estimated $354K sold.

Vestcor Inc first reported a position in EBAC in Q2 2021 and held it in 7 quarters. The position peaked at $354K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBAC as of Q1 2023.

Vestcor Inc reported no remaining European Biotech Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Vestcor Inc sold 35,000 European Biotech Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $354K.
Vestcor Inc first reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares in Q2 2021 and held it in 7 quarters.
Vestcor Inc's European Biotech Acquisition Corp. Class A Ordinary Shares position peaked at $354K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on Vestcor Inc's 13F filing for Q1 2023, filed 15 May 2023.